Skip to main content

Candido Diaz Lagares

Institutions of which they are part

Postdoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Candido Diaz Lagares

Institutions of which they are part

Postdoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Research lines

Critical Oncohematology

In close collaboration with the Oncology research group and the Hematology research group, the research line of Critical Oncohematology, has as a main objective the study of the complications associated to experimental treatments of the oncohematogy patients

IP: Candido Diaz Lagares

Projects

Shock, Disfunció Orgànica i Ressucitació

IP: Ricard Ferrer Roca
Collaborators: César Laborda Soriano, Alejandra García Roche, Candido Diaz Lagares, Rosa Maria Gracia Gozalo, Rosa Alcaraz Peñarrocha, Juan Carlos Ruiz Rodriguez, Xavier Nuvials Casals, Judith Sacanell Lacasa, Marcos Pérez Carrasco, José Alonso Fajardo, Adolfo Ruiz Sanmartin, Óscar Mula Castellón, Anna Sánchez Corral, Elisabeth Papiol Gallofré, Luis silvestre Chiscano Camon, Eduard Argudo Serra, Maria Martinez Martinez, Jordi Riera del Brío, Raquel Albertos Martell, Noemí Varga , Sofia Contreras Medina, Andres Francisco Pacheco Reyes, Manuel Roberto Sosa Garay, Camilo andres Bonilla Rojas, Manuel Roberto Sosa Garay
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00798
Duration: 01/01/2022 - 30/06/2025

Clinical Research / Innovation in Pneumonia & Sepsis (CRIPS) (GRC)

IP: Clinical Research / Innovation in Pneumonia & Sepsis (CRIPS) (GRC)
Collaborators: Candido Diaz Lagares, Yolanda Peña Lopez, Jordi Riera del Brío, Teresa Pont Castellana
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 28800
Reference: 2014 SGR 278
Duration: 01/01/2014 - 31/12/2016

Related news

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

SOFA-2 is being updated after thirty years to incorporate advances in diagnosis, monitoring and life support.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Manuel López Paredes

Manuel López Paredes

Head of group
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Maria Vidal Burdeus

Maria Vidal Burdeus

Predoctoral researcher
Cardiovascular Diseases
Read more
Eladia Montserrat Tauste Rubio

Eladia Montserrat Tauste Rubio

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Victor Pallares Lopez

Victor Pallares Lopez

Gestió i Administració
Directorate of Innovation and Business Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.